ABSTRACT
Abstract Fibromyalgia (FM) is a nonarticular rheumatic syndrome that leads to diffuse myalgia, sleep disturbances and morning stiffness. Balneotherapy has been shown an effective strategy to improve the health conditions of patients; however, the treatment follow-up is based on patient report due to the lack of biomarkers. Thus, this study evaluated the application of cytokines and phosphoglycerate mutase I (PGAM-I) to monitoring FM patient underwent to balneotherapy treatment. Eleven healthy and eleven women with FM were submitted to daily sessions of balneotherapy during 10 days. Clinical and quality of life parameters were assessed through a FIQ questionnaire. Blood levels of TNF-(, interleukins (IL-1, IL-2 and IL-10) and PGAM-I expression in patients' saliva were also evaluated. Patients with FM showed significant improvements in their clinical status after treatment. Also, FM patients has IL-10 levels lower than healthy women and the balneotherapy increased the expression of this cytokine in both groups, concomitantly to pain relief. Although inflammatory cytokines (IL-1, IL-2 and TNF-() were more expressed in FM patients than healthy patients their levels did not reduce after treatment. A slight increase of PGAM-I expression was observed. In conclusion, IL-10 levels could be a useful biomarker to balneotherapy follow-up of FM patients. However, these findings must be analyzed in a larger number of patients in order to validate IL-10 as an effective biomarker.
Subject(s)
Humans , Female , Biomarkers , Fibromyalgia/diagnosis , Interleukin-10/blood , Quality of Life , Saliva , Balneology , Fibromyalgia/therapy , Case-Control Studies , Surveys and Questionnaires , Interleukin-1/blood , Interleukin-2/blood , Phosphoglycerate Mutase/bloodABSTRACT
Anatoxins are powerful neuromuscular blocking agents produced by some cyanobacteria. Consumption of anatoxin-producing cyanobacterial mats or the water containing them has been linked to numerous animal poisonings and fatalities worldwide. Despite this health risk, there is a poor understanding of the environmental factors regulating anatoxin production. Non-axenic Phormidium autumnale strain CAWBG557 produces anatoxin-a (ATX), homoanatoxin-a (HTX) and their dihydrogen-derivatives dihydroanatoxin-a (dhATX) and dihydrohomoanatoxin-a (dhHTX). The effects of varying nitrogen and phosphorus concentrations on the production of these four variants were examined in batch monocultures. The anatoxin quota (anatoxin per cell) of all four variants increased up to four fold in the initial growth phase (days 0-9) coinciding with the spread of filaments across the culture vessel during substrate attachment. Dihydroanatoxin-a and dhHTX, accounted for over 60% of the total anatoxin quota in each nitrogen and phosphorus treatment. This suggests they are being internally synthesised and not just derived following cell lysis and environmental degradation. The four anatoxin variants differed in their response to varying nitrogen and phosphorus concentrations. Notably, dhATX quota significantly decreased (P ≤ 0.03) when nitrogen and phosphorus concentrations were elevated (nitrogen = 21 mg L(-1); phosphorus = 3 mg L(-1)), while HTX quota increased when the phosphorus concentrations were reduced (ca. < 0.08 mg L(-1)). This is of concern as HTX has a high toxicity and anatoxin producing P. autumnale blooms in New Zealand usually occur in rivers with low water column dissolved reactive phosphorus.